To determine the phenotype of patients having PMR symptoms and primary Sjogren syndrome (pSS), we used a French national call to identify patients combining both diseases and collected retrospective clinical and biological data.
A national call to identify patients combining pSS and PMR was disseminated in France. Patients with Sjögren's syndrome associated with rheumatoid arthritis were excluded. We described the global population having both diseases and compared them to two historic prospective cohorts of isolated pSS (the prospective cohort of primary Sjögren DiapSS), or isolated PMR (TENOR, a cohort of recent PMR), regarding clinical, imaging and treatments characteristics.
Study Type
OBSERVATIONAL
Enrollment
15
CHRU Brest
Brest, France
RECRUITINGclinical data
pain (pain scale)
Time frame: at diagnosis
biological data
biology (CRP in mg/L)
Time frame: at diagnosis
biological data
presence of anti-SSA/SSB (yes/no)
Time frame: at diagnosis
histological data
accesories salivary glands biopsies (focus score)
Time frame: at diagnosis
imaging data
US (presence of shoulder involvement yes/no; hip involvement yes/no)
Time frame: at diagnosis
treatments data
use of methotrexate yes/no; abatacept yes/no, rituximab yes/no, corticosteroids yes/no; pilocarpine yes/no; hydroxychloroquine yes/no
Time frame: at inclusion ( day 0)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.